Next |
home / stock / cntx / cntx message board
Subject | By | Source | When |
---|---|---|---|
$CNTX .65. Just needs to squeeze back | BooDog | investorshub | 04/18/2023 12:07:20 PM |
Nice pop! Summertime's coming!!! | BooDog | investorshub | 04/04/2023 5:23:44 PM |
(1) The purchases reported in this Form 4 | BooDog | investorshub | 02/14/2023 1:04:09 PM |
Thank you for all your DD. I can't | vegasopc | investorshub | 02/03/2023 12:53:48 PM |
I dug even deeper... The merger between Stemline | BooDog | investorshub | 02/03/2023 12:39:20 PM |
Now I'm wondering if my email is hacked. | vegasopc | investorshub | 02/03/2023 12:26:52 PM |
pipeline is strong and their cashflow is strong. | BooDog | investorshub | 02/03/2023 12:00:09 PM |
file bk?????? | cary73 | investorshub | 02/03/2023 9:23:30 AM |
Shares are worthless. Filed BK. | vegasopc | investorshub | 02/02/2023 3:17:00 PM |
I'm out. BK | vegasopc | investorshub | 02/02/2023 12:12:11 PM |
$$$CNTX$$$ HOLY COW!!! $$$ | vegasopc | investorshub | 02/01/2023 3:03:54 PM |
$$$CNTX$$$ Very interesting start. Back in. $$$ | vegasopc | investorshub | 02/01/2023 2:54:08 PM |
but can you read a piece of news...??? | cary73 | investorshub | 02/01/2023 1:45:56 PM |
znewcar1: $CNTX 55% v76,0M c1.06 f15,966M hod1.55 ML.62 gapNcrap x2 this month | znewcar1 | investorshangout | 01/31/2023 10:50:27 PM |
Exactly. Gap and trap and new bagholders. | BooDog | investorshub | 01/31/2023 10:28:21 PM |
More sells than buys, now you know why | cash4 | investorshub | 01/31/2023 8:42:35 PM |
Naked shorting from hell | Daytrader2013 | investorshub | 01/31/2023 7:02:19 PM |
If this is the best it can do | cash4 | investorshub | 01/31/2023 5:25:43 PM |
I loaded 1.10. As much as I | BooDog | investorshub | 01/31/2023 4:48:54 PM |
#unreal hoe much you leave on that table $27 | TheFinalCD | investorshub | 01/31/2023 4:46:45 PM |
News, Short Squeeze, Breakout and More Instantly...
Context Therapeutics Inc. Company Name:
CNTX Stock Symbol:
NASDAQ Market:
PHILADELPHIA, April 01, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that on March 28, 2024, the Company submitted an Investigational Ne...
CTIM-76 IND filing on track for late March 2024 Cash and cash equivalents of $14.4 million as of December 31, 2023 Company expects its cash and cash equivalents will continue to fund operations into late 2024 PHILADELPHIA, March 21, 2024 (GLOBE NEWSWIRE) -- Context Therape...
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter finan...